Evidence map›Paper›PMID 42615015›Full record

ArticleSchizophrenia bulletin open2026

From Micro Molecular to Functional Levels Through Macro Structures: Mediation of Structural Brain Changes on the Relationship Between Oxidative Stress and Cognition in Early Onset Psychosis.

Mara Villar-Arenzana, Belén Taulero-Escalera, Karina S MacDowell, David Fraguas, Igor Bombin, Josefina Castro-Fornieles, Carmen Moreno, Inmaculada Baeza, Elena de la Serna, Ana González-Pinto and 5 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mara Villar-ArenzanaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, 28007, Madrid, Spain.
Belén Taulero-EscaleraDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, 28007, Madrid, Spain.
Karina S MacDowellDepartment of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid (UCM), CIBERSAM, Imas12, IUIN-UCM, Spanish network in stress research (REIS), 28040, Madrid, Spain.
David FraguasDepartment of Psychiatry and Mental Health, Hospital Universitario Príncipe de Asturias, CIBERSAM, 28805, Madrid, Spain.
Igor BombinDepartment of Neuropsychology, Reintegra Foundation, 33011, Oviedo, Spain.
Josefina Castro-FornielesChild Psychiatry and Psychology Department, 2017SGR881, Neurosciences Institute, Hospital Clinic de Barcelona, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi Sunyer), CIBERSAM, Department of Medicine University of Barcelona, 08036, Barcelona, Spain.
Carmen MorenoChild Psychiatry Department, Hospital Universitario La Paz, IdiPAZ, CIBERSAM, ISCIII, 28046, Madrid, Spain.
Inmaculada BaezaChild Psychiatry and Psychology Department, 2017SGR881, Neurosciences Institute, Hospital Clinic de Barcelona, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi Sunyer), CIBERSAM, Department of Medicine University of Barcelona, 08036, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2611-5781
Elena de la SernaChild Psychiatry and Psychology Department, 2017SGR881, Neurosciences Institute, Hospital Clinic de Barcelona, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi Sunyer), CIBERSAM, Department of Medicine University of Barcelona, 08036, Barcelona, Spain.
Ana González-PintoBIOARABA, CIBERSAM, Kronikgune, EHU-UPV, Hospital Universitario de Álava, 01009, Vitoria, Spain.
Mara ParelladaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, 28007, Madrid, Spain.
Beatriz PayáDepartment of Child Psychiatry, Hospital Universitario Marqués de Valdecilla, CIBERSAM, 39008, Santander, Spain.
Montserrat GraellPsychiatry and Psychology Department, Hospital Infantil Universitario Niño Jesús, CIBERSAM, 28009, Madrid, Spain.
Christos PantelisDepartment of Psychiatry, The University of Melbourne, 3010, VIC, Australia.ORCID https://orcid.org/0000-0002-9565-0238
Marta Rapado-CastroDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, 28007, Madrid, Spain.

Funding

ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2M
Randomized controlled trial of enhanced coordinated specialty care (CSC 2.0)P50MH115846 · NIMH · MCLEAN HOSPITAL · PI Dost Ongur · 2019 to 2026
$16.9M
The impact of social isolation on aging health in schizophreniaR01MH128971 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ABRAHAM REICHENBERG, Eva Velthorst · 2022 to 2026
$3.2M
NIMH NIH HHS P50 MH115846NIMH NIH HHS R01 MH128971NIMH NIH HHS U01 MH124639
6 · The paper itself

Abstract

Background: Previous findings showed decreased frontal left gray matter (FLGM) volume predicted working memory impairments over 2 years after first-episode psychosis (FEP) in adolescents, as a function of age. However, the interplay between brain changes and cognitive development is not well understood. Oxidative stress (STOX), specifically lower baseline glutathione (GSH) levels, has been linked to greater FLGM volume loss and cognitive impairments in this same sample group. This study further investigated the relationship between baseline GSH levels, longitudinal brain changes, and cognitive impairments in FEP compared to healthy controls. We hypothesized that lower baseline GSH levels and accelerated FLGM volume loss underlie working memory deficits over time in adolescent FEP. Methods: GSH levels were measured in peripheral blood at baseline. Regional FLGM volume was obtained using automated methods based on Talairach's. Mediation analyses were conducted using regression and bootstrapping techniques. Results: We confirmed the association between lower GSH levels at the time of FEP and FLGM volume loss, and between decreased FLGM volume and decreased working memory over the first 2 years after onset. STOX had an indirect effect on impaired working memory in adolescent psychosis, where decreased FLGM was a mediator. No association was found in controls. Conclusions: Lower baseline GSH levels negatively impacted FLGM volume, contributing to working memory impairments in adolescent psychosis. Biomolecular and macrostructural alterations (lower GSH, FLGM atrophy) may underlie functional cognitive outcomes like working memory deficits longitudinally. These findings may elucidate how STOX relates to neuroanatomical changes that disrupt cognitive trajectories during adolescent brain maturation in FEP.

Indexed as

adolescencebrain volumecognitionfirst episode of psychosisglutathionegray mattermagnetic resonance imagingoxidative stressworking memory

Identifiers

PMID42615015
PMCPMC13485157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.